Scavenging effect of nicorandil on free radicals and lipid peroxide in streptozotocin-induced diabetic rats

被引:54
作者
Mano, T
Shinohara, R
Nagasaka, A
Nakagawa, H
Uchimura, K
Hayashi, R
Nakano, I
Tsugawa, T
Watanabe, F
Kobayashi, T
Fujiwara, K
Nakai, A
Itoh, M
机构
[1] Fujita Hlth Univ, Sch Med & Hyg, Dept Internal Med & Pharm, Aichi, Japan
[2] Fujita Hlth Univ, Sch Med & Hyg, Dept Biochem, Aichi, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2000年 / 49卷 / 04期
关键词
D O I
10.1016/S0026-0495(00)80003-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Free radicals and lipid peroxide (LPO), easily formed in the diabetic state, play an important role in the development of diabetic complications. Potentially, nicorandil may reduce the production of free radicals and LPO in various organs. In fact, increased LPO levels in the serum, kidney, and cardiac muscle of diabetic (DM) rats were reduced by nicorandil treatment (N treatment). Xanthine oxidase (XOD), which produces free radicals, was decreased in the liver and increased in the kidney of DM rats compared with control rats, and these changes were prevented by N treatment. The concentration of Cu, Zn-superoxide dismutase (SOD) decreased in the cardiac muscle and increased in the kidney of DM rats, and these changes returned to normal after N treatment. The decreased concentration of Mn-SOD in the liver, kidney, and cardiac muscle from DM rats was also reversed by N treatment. The changes in catalase and glutathione peroxidase (GSH-PX) activities in DM rats were not improved effectively by N treatment. Another K-adenosine triphosphate (K-ATP) channel opener, tilisolol hydrochloride, had an effect similar to that of nicorandil. The effects of nicorandil and tilisolol were studied only in DM rats. These data imply that N treatment, as an antioxidative therapy, may be beneficial in preventing diabetic complications due to lipoperoxidation and free radicals in DM rats. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:427 / 431
页数:5
相关论文
共 37 条
[1]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]  
ASAYAMA K, 1989, DIABETES RES CLIN EX, V12, P85
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Influence of nitric oxide on luminol-enhanced chemiluminescence measured from porcine-stimulated leukocytes [J].
Demiryurek, AT ;
Kennedy, S ;
Wainwright, CL ;
Wadsworth, RM ;
Kane, KA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (03) :332-337
[5]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF K+ CHANNEL OPENERS [J].
EDWARDS, G ;
WESTON, AH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (10) :417-422
[6]   INHIBITION OF NITRITE FORMATION FROM HYDROXYLAMMONIUM-CHLORIDE - SIMPLE ASSAY FOR SUPEROXIDE-DISMUTASE [J].
ELSTNER, EF ;
HEUPEL, A .
ANALYTICAL BIOCHEMISTRY, 1976, 70 (02) :616-620
[7]   CARDIOPROTECTIVE EFFECTS OF NICORANDIL [J].
GROSS, GJ ;
AUCHAMPACH, JA ;
MARUYAMA, M ;
WARLTIER, DC ;
PIEPER, GM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S22-S28
[8]   NEW SPECTROPHOTOMETRIC ASSAY METHOD OF XANTHINE-OXIDASE IN CRUDE TISSUE HOMOGENATE [J].
HASHIMOTO, S .
ANALYTICAL BIOCHEMISTRY, 1974, 62 (02) :426-435
[9]   Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, alpha-crystallin [J].
Heath, MM ;
Rixon, KC ;
Harding, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1315 (03) :176-184
[10]  
HOCHSTEI.P, 1968, MOL PHARMACOL, V4, P574